Renal Cell Cancer Clinical Trials

A listing of Renal Cell Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Scottsdale Arizona 85258

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

California

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

San Francisco California 94143

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Colorado

Aurora Colorado 80045

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132

Connecticut

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of IMMU-132

Delaware

Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

UPDATED

Washington District of Columbia 20007

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Florida

Orlando Florida 32806

Patients are needed to participate in a clinical research study of IMMU-132

Tampa Florida 33612

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Georgia

Athens Georgia 30607

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Newnan Georgia 30265

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Illinois

Park Ridge Illinois 60068

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Zion Illinois 60099

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Indiana

Goshen Indiana 46526

Patients are needed to participate in a clinical research study of IMMU-132

Louisiana

UPDATED

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Maine

UPDATED

Brunswick Maine 04011

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Kennebunk Maine 04043

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Scarborough Maine 04074

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Maryland

Bethesda Maryland 20892

Patients are needed to participate in a clinical research study evaluating hetIL-15 for the treatment of Skin Melanoma, Renal Cell Cancer, Non-Small Cell Lung Cancer or Head and Neck Squamous Cell Carcinoma

Massachusetts

UPDATED

Boston Massachusetts 02215

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

UPDATED

Boston Massachusetts 02115

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

UPDATED

Boston Massachusetts 02215

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Boston Massachusetts 02114

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of IMMU-132

Michigan

Ann Arbor Michigan 48109

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Detroit Michigan 48201

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Detroit Michigan 48202

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Minnesota

Minneapolis Minnesota 55455

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Missouri

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Montana

UPDATED

Billings Montana 59102

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Billings Montana 59101

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

New Hampshire

Lebanon New Hampshire 03756

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

New York

East Setauket New York 11733

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

New York New York 10022

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

New York New York 10032

Patients are needed to participate in a clinical research study of IMMU-132

New York New York 10021

Patients are needed to participate in a clinical research study of IMMU-132

Ohio

UPDATED

Cleveland Ohio 44195

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Cleveland Ohio 44195

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Columbus Ohio 43210

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors